For years, pharmaceutical and biotechnology companies have employed the strategy of establishing preferred provider relationships in order to streamline the process of outsourcing clinical research studies. Often the preferred provider would provide discounts to their customers based on efficiencies the service provider may realize from working on multiple trials for a single compound or the sponsor organization. Typically the preferred partnerships focused on the selection of one service organization providing all of the functional services for a clinical trial. While there were cost-savings experienced by the sponsor, often the result was that the service provider with the greatest clinical strength received the designation of preferred provider, but then the sponsor was “stuck” with that service provider or additional services from that provider that were not as good.
| File |
|---|
 The Benefits of Employing a Functional Service Provider |
